Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Friday, April 26, 2024 · 706,709,801 Articles · 3+ Million Readers

Heparin Market - North America Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2022

Wise.Guy12

Wise.Guy.

PUNE, INDIA, April 16, 2018 /EINPresswire.com/ -- WiseGuyRerports.com Presents “North America Heparin Market by Manufacturers, Countries, Type and Application, Forecast to 2022” New Document to its Studies Database

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine

Scope of the Report:
This report focuses on the Heparin in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers
Hepalink
Changshan Pharm
Qianhong Bio-pharma
Opocrin
Pfizer
Aspen Oss
King-friend Biochemical Pharmaceutical
Bioibérica
Dongcheng Biochemicals
Jiulong Biochemicals
Tiandong
Xinbai
Yino Pharma Limited
Deebio

Request For Sample Report @ https://www.wiseguyreports.com/sample-request/2581378-north-america-heparin-market-by-manufacturers-countries-type-and-application-forecast

Market Segment by Countries, covering
United States
Canada
Mexico

Market Segment by Type, covers
Heparin Sodium
Heparin Calcium
Other

Market Segment by Applications, can be divided into
UFH
LMWH

 

Complete Repor Details @ https://www.wiseguyreports.com/reports/2581378-north-america-heparin-market-by-manufacturers-countries-type-and-application-forecast

Table Of Contents:                                                                                                                          

1 Market Overview
1.1 Heparin Introduction
1.2 Market Analysis by Type
1.2.1 Heparin Sodium
1.2.2 Heparin Calcium
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 UFH
1.3.2 LMWH
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Mexico Status and Prospect (2012-2022)
1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Hepalink
2.1.1 Profile
2.1.2 Heparin Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Hepalink Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Hepalink News
2.2 Changshan Pharm
2.2.1 Profile
2.2.2 Heparin Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Changshan Pharm Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Changshan Pharm News
2.3 Qianhong Bio-pharma
2.3.1 Profile
2.3.2 Heparin Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Qianhong Bio-pharma Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Qianhong Bio-pharma News
2.4 Opocrin
2.4.1 Profile
2.4.2 Heparin Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Opocrin Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Opocrin News
2.5 Pfizer
2.5.1 Profile
2.5.2 Heparin Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Pfizer Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Pfizer News

 Continued…….

 

CONTACT US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

 

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release